Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016

REFERENCES

• Chen C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty 2016; 5:47; PMID:27251305; http://dx.doi.org/10.1186/s40249-016-0143-8
   PubMed Web of Science ®Google Scholar
• Prusiner SB. The prion diseases. Brain Pathol 1998; 8:499-513; PMID:9669700; http://dx.doi.org/10.1111/j.1750-3639.1998.tb00171.x
   PubMed Web of Science ®Google Scholar
• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618-28; PMID:22710755; http://dx.doi.org/10.1016/S1474-4422(12)70063-7
   PubMed Web of Science ®Google Scholar
• Budka H, Will RG. The end of the BSE saga: do we still need surveillance for human prion diseases? Swiss Med Wkly 2015; 145:w14212
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Surveillance for Creutzfeldt-Jakob disease–United States. MMWR Morb Mortal Wkly Rep 1996; 45:665-8; PMID:8769655
   PubMedGoogle Scholar
• Cousens SN, Zeidler M, Esmonde TF, De Silva R, Wilesmith JW, Smith PG, Will RG. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970–96. BMJ 1997; 315:389-95; PMID:9277601; http://dx.doi.org/10.1136/bmj.315.7105.389
   PubMed Web of Science ®Google Scholar
• Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie-Lauprêtre N, et al. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000; 53:747-54; PMID:10941953; http://dx.doi.org/10.1016/S0895-4356(99)00207-3
   PubMed Web of Science ®Google Scholar
• Lu CJ, Sun Y, Chen SS. Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance. Eur J Epidemiol 2010; 25:341-7; PMID:20333444; http://dx.doi.org/10.1007/s10654-010-9446-4
   PubMed Web of Science ®Google Scholar
• Litzroth A, Cras P, De Vil B, Quoilin S. Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998–2012. BMC Neurol 2015; 15:250; PMID:26630984; http://dx.doi.org/10.1186/s12883-015-0507-x
   PubMed Web of Science ®Google Scholar
• Stratton E. Surveillance for Creutzfeldt-Jakob disease in Canada. Can Commun Dis Rep 1999; 25:7-8; PMID:9926624
   PubMedGoogle Scholar
• Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007; 130:1350-9; PMID:17472986; http://dx.doi.org/10.1093/brain/awm063
   PubMed Web of Science ®Google Scholar
• Lim JS, Kwon HM, Jang JW, Ju YR, Kim S, Park YH, Park SY, Kim S. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program. Prion 2015; 9:136-43; PMID:25996401; http://dx.doi.org/10.1080/19336896.2015.1022020
   PubMed Web of Science ®Google Scholar
• Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 2002; 110:88-98; PMID:12064260; http://dx.doi.org/10.1034/j.1600-0463.2002.100111.x
   PubMed Web of Science ®Google Scholar
• Wood H. Prion disease: New approaches to CJD diagnosis. Nat Rev Neurol 2012; 8:241; PMID:22487751; http://dx.doi.org/10.1038/nrneurol.2012.59
   PubMedGoogle Scholar
• Shi Q, Gao C, Zhou W, Zhang BY, Chen JM, Tian C, Jiang HY, Han J, Xiang NJ, Wang XF, et al. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. BMC Public Health 2008; 8:360; PMID:18928564; http://dx.doi.org/10.1186/1471-2458-8-360
   PubMed Web of Science ®Google Scholar
• Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, Zhang BY, Jiang HY, Zhang J, Dong XP. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One 2011; 6:e24231; PMID:21904617; http://dx.doi.org/10.1371/journal.pone.0024231
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhou W, Chen C, Zhang BY, Xiao K, Zhang XC, Shen XJ, Li Q, Deng LQ, Dong JH, et al. The Features of Genetic Prion Diseases Based on Chinese Surveillance Program. PLoS One 2015; 10:e0139552
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhang XC, Zhou W, Xiao K, Chen C, Zhang HY, Sun JY, Chen LN, Zhang XM, Han J, et al. Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease. Prion 2015; 9:304-14; PMID:26251963; http://dx.doi.org/10.1080/19336896.2015.1075115
   PubMed Web of Science ®Google Scholar
• Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Jellinger K, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5:459-66; PMID:8974629; http://dx.doi.org/10.1111/j.1750-3639.1995.tb00625.x
   PubMed Web of Science ®Google Scholar
• Perry DC, Geschwind MD. Thorough work-up and new diagnostic criteria needed for CJD. Nat Rev Neurol 2011; 7:479-80; PMID:21892213; http://dx.doi.org/10.1038/nrneurol.2011.118
   PubMed Web of Science ®Google Scholar